Cargando…

Prediction of breast cancer sensitivity to neoadjuvant chemotherapy based on status of DNA damage repair proteins

INTRODUCTION: Various agents used in breast cancer chemotherapy provoke DNA double-strand breaks (DSBs). DSB repair competence determines the sensitivity of cells to these agents whereby aberrations in the repair machinery leads to apoptosis. Proteins required for this pathway can be detected as nuc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Asakawa, Hideki, Koizumi, Hirotaka, Koike, Ayaka, Takahashi, Makiko, Wu, Wenwen, Iwase, Hirotaka, Fukuda, Mamoru, Ohta, Tomohiko
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2879561/ https://www.ncbi.nlm.nih.gov/pubmed/20205718 http://dx.doi.org/10.1186/bcr2486

Ejemplares similares

Perturbation of DNA repair pathways by proteasome inhibitors corresponds to enhanced chemosensitivity of cells to DNA damage-inducing agents
por: Takeshita, Takashi, et al.
Publicado: (2009)

A case of synchronous bilateral breast cancer with different pathological responses to neoadjuvant chemotherapy with different biological character
por: Hayashi, Mitsuhiro, et al.
Publicado: (2013)

The ubiquitin E3 ligase activity of BRCA1 and its biological functions
por: Wu, Wenwen, et al.
Publicado: (2008)

APOBEC3B gene expression as a novel predictive factor for pathological complete response to neoadjuvant chemotherapy in breast cancer
por: Fujiki, Yoshitaka, et al.
Publicado: (2018)

BRCAness as an Important Prognostic Marker in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy: A Multicenter Retrospective Study
por: Kosaka, Yoshimasa, et al.
Publicado: (2020)

DNA Damage and Repair Biomarkers in Cervical Cancer Patients Treated with Neoadjuvant Chemotherapy: An Exploratory Analysis
por: Vici, Patrizia, et al.
Publicado: (2016)

Clinical outcomes and prognostic factors in patients with stage II-III breast cancer treated with neoadjuvant chemotherapy followed by surgery and postmastectomy radiation therapy in the modern treatment era
por: Nakajima, Naomi, et al.
Publicado: (2018)

Accuracy of magnetic resonance imaging for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy: association with breast cancer subtype
por: Fukuda, Takayo, et al.
Publicado: (2016)

The Sensitivity Prediction of Neoadjuvant Chemotherapy for Gastric Cancer
por: Sun, Juan, et al.
Publicado: (2021)

Plasma microRNA‐192‐5p can predict the response to neoadjuvant chemotherapy and prognosis in esophageal cancer
por: Furuke, Hirotaka, et al.
Publicado: (2022)

The efficiency of neoadjuvant chemotherapy in colon cancer with mismatch repair deficiency
por: Yunlong, Wu, et al.
Publicado: (2022)

A reproducible swine model of a surgically created saccular thoracic aortic aneurysm
por: Fukushima, Soichiro, et al.
Publicado: (2021)

Protective effects of mangafodipir against chemotherapy-induced ovarian damage in mice
por: Qin, Ying, et al.
Publicado: (2018)

Class I histone deacetylase inhibitors inhibit the retention of BRCA1 and 53BP1 at the site of DNA damage
por: Fukuda, Takayo, et al.
Publicado: (2015)

Predictive significance of DNA damage and repair biomarkers in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: An exploratory analysis
por: Vici, Patrizia, et al.
Publicado: (2015)

Pitfalls of invasive blood pressure monitoring using the caudal ventral artery in rats
por: Ohta, Hiroki, et al.
Publicado: (2017)

Clinical significance of estrogen receptor β in breast and prostate cancer from biological aspects
por: Omoto, Yoko, et al.
Publicado: (2015)

Lenvatinib: A Promising Molecular Targeted Agent for Multiple Cancers
por: Suyama, Koichi, et al.
Publicado: (2018)

B-Cell Lymphoma of the Middle Ear Treated with Multidrug Chemotherapy in a Cat
por: Takahashi, Tomoko, et al.
Publicado: (2023)

Infant’s Behaviour Checklist for low birth weight infants and later neurodevelopmental outcome
por: Kihara, Hideki, et al.
Publicado: (2021)

GR, Sgk1, and NDRG1 in esophageal squamous cell carcinoma: their correlation with therapeutic outcome of neoadjuvant chemotherapy
por: Ueki, Shunsuke, et al.
Publicado: (2020)

A CDC7 inhibitor sensitizes DNA-damaging chemotherapies by suppressing homologous recombination repair to delay DNA damage recovery
por: Iwai, Kenichi, et al.
Publicado: (2021)

Identification of Sensitivity Predictors of Neoadjuvant Chemotherapy for the Treatment of Adenocarcinoma of Gastroesophageal Junction
por: Li, Shoumiao, et al.
Publicado: (2017)

Survival in Cytologically Proven Node-Positive Breast Cancer Patients with Nodal Pathological Complete Response after Neoadjuvant Chemotherapy
por: Inari, Hitoshi, et al.
Publicado: (2020)

Long-Term Effects of Half-Time Photodynamic Therapy on Retinal Sensitivity in Eyes with Chronic Central Serous Chorioretinopathy
por: Iwase, Takehito, et al.
Publicado: (2020)

The number of osteoclasts in a biopsy specimen can predict the efficacy of neoadjuvant chemotherapy for primary osteosarcoma
por: Araki, Yoshihiro, et al.
Publicado: (2021)

Impact of body fat distribution on neoadjuvant chemotherapy outcomes in advanced breast cancer patients
por: Iwase, Toshiaki, et al.
Publicado: (2015)

Successful neoadjuvant chemotherapy for large cell neuroendocrine carcinoma of the cervix: A case report()
por: Omori, Makiko, et al.
Publicado: (2013)

Marmoset angiography just by percutaneous puncture of the caudal ventral artery
por: Ohta, Hiroki, et al.
Publicado: (2021)

Predictive Factors and Value of ypN+ after Neoadjuvant Chemotherapy in Clinically Lymph Node-Negative Breast Cancer
por: Fukada, Ippei, et al.
Publicado: (2016)

Predictive value of DNA repair gene expression for response to neoadjuvant chemotherapy in breast cancer
por: Kneubil, M.C., et al.
Publicado: (2022)

Metabolic Profiling of Bladder Cancer Patients’ Serum Reveals Their Sensitivity to Neoadjuvant Chemotherapy
por: Zhuang, Juntao, et al.
Publicado: (2022)

Encapsulating fibrosis following neoadjuvant chemotherapy is correlated with outcomes in patients with pancreatic cancer
por: Matsuda, Yoko, et al.
Publicado: (2019)

The BARD1/HP1 interaction: Another clue to heterochromatin involvement in homologous recombination
por: Fukuda, Takayo, et al.
Publicado: (2015)

Neoadjuvant chemotherapy for primary sarcoma of the breast: a case report
por: Miyazaki, Chieko, et al.
Publicado: (2019)

Nab-paclitaxel for the treatment of breast cancer: efficacy, safety, and approval
por: Yamamoto, Yutaka, et al.
Publicado: (2011)

The role of exosomal microRNAs; focus on clinical applications in breast cancer
por: Sueta, Aiko, et al.
Publicado: (2019)

Clinical management and outcome of four-toed hedgehogs (Atelerix albiventris) with histiocytic sarcoma
por: KOIZUMI, Iori, et al.
Publicado: (2019)

A case of primary pulmonary leiomyosarcoma completely resected after neoadjuvant chemotherapy
por: Tanaka, Kazuhisa, et al.
Publicado: (2019)

Clinical effects of Apatinib combined with DOS neoadjuvant chemotherapy regimen in neoadjuvant chemotherapy for LAGC
por: Zhou, Peng-zhe, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3sbm5ve9ftb8vl2vtuusqk5cvc